2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole

C193H133N15O5S — CID 160776004

IUPAC2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole
SMILESO=C1c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc2C(=O)c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc21.O=S1(=O)c2ccc(N3c4ccccc4N(c4ccccc4)c4ccccc43)cc2Cc2cc(N3c4ccccc4N(c4ccccc4)c4ccccc43)ccc21.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)n2-c2ccccc2)cc1.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)o2)cc1
InChIInChI=1S/C74H50N2O2.C49H34N4O2S.C38H27N5.C32H22N4O/c77-73-70-48-34-62(60-31-45-68(46-32-60)76(65-39-25-57(26-40-65)53-17-9-3-10-18-53)66-41-27-58(28-42-66)54-19-11-4-12-20-54)50-72(70)74(78)69-47-33-61(49-71(69)73)59-29-43-67(44-30-59)75(63-35-21-55(22-36-63)51-13-5-1-6-14-51)64-37-23-56(24-38-64)52-15-7-2-8-16-52;54-56(55)48-29-27-38(52-44-23-11-7-19-40(44)50(36-15-3-1-4-16-36)41-20-8-12-24-45(41)52)32-34(48)31-35-33-39(28-30-49(35)56)53-46-25-13-9-21-42(46)51(37-17-5-2-6-18-37)43-22-10-14-26-47(43)53;1-4-14-28(15-5-1)37-39-40-38(43(37)31-18-8-3-9-19-31)29-24-26-32(27-25-29)42-35-22-12-10-20-33(35)41(30-16-6-2-7-17-30)34-21-11-13-23-36(34)42;1-3-11-23(12-4-1)31-33-34-32(37-31)24-19-21-26(22-20-24)36-29-17-9-7-15-27(29)35(25-13-5-2-6-14-25)28-16-8-10-18-30(28)36/h1-50H;1-30,32-33H,31H2;1-27H;1-22H
InChIKeyRZYKPWTYMHCIKU-UHFFFAOYSA-N
MW2774.35 g/mol
LogP50.84
Rot. Bonds25

About 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole

2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole (PubChem CID 160776004) has the molecular formula C193H133N15O5S and a molecular weight of 2774.35 g/mol. Its IUPAC name is 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole
PubChem CID160776004
Molecular FormulaC193H133N15O5S
Molecular Weight2774.35 g/mol
Exact Mass2772.03
IUPAC Name2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole
SMILESO=C1c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc2C(=O)c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc21.O=S1(=O)c2ccc(N3c4ccccc4N(c4ccccc4)c4ccccc43)cc2Cc2cc(N3c4ccccc4N(c4ccccc4)c4ccccc43)ccc21.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)n2-c2ccccc2)cc1.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)o2)cc1
InChIInChI=1S/C74H50N2O2.C49H34N4O2S.C38H27N5.C32H22N4O/c77-73-70-48-34-62(60-31-45-68(46-32-60)76(65-39-25-57(26-40-65)53-17-9-3-10-18-53)66-41-27-58(28-42-66)54-19-11-4-12-20-54)50-72(70)74(78)69-47-33-61(49-71(69)73)59-29-43-67(44-30-59)75(63-35-21-55(22-36-63)51-13-5-1-6-14-51)64-37-23-56(24-38-64)52-15-7-2-8-16-52;54-56(55)48-29-27-38(52-44-23-11-7-19-40(44)50(36-15-3-1-4-16-36)41-20-8-12-24-45(41)52)32-34(48)31-35-33-39(28-30-49(35)56)53-46-25-13-9-21-42(46)51(37-17-5-2-6-18-37)43-22-10-14-26-47(43)53;1-4-14-28(15-5-1)37-39-40-38(43(37)31-18-8-3-9-19-31)29-24-26-32(27-25-29)42-35-22-12-10-20-33(35)41(30-16-6-2-7-17-30)34-21-11-13-23-36(34)42;1-3-11-23(12-4-1)31-33-34-32(37-31)24-19-21-26(22-20-24)36-29-17-9-7-15-27(29)35(25-13-5-2-6-14-25)28-16-8-10-18-30(28)36/h1-50H;1-30,32-33H,31H2;1-27H;1-22H
InChIKeyRZYKPWTYMHCIKU-UHFFFAOYSA-N
XLogP50.84
TPSA170.31 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms214
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002774.35
LogP ≤ 550.84
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}

Analyze 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-[3-[10-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-5-phenylphenazin-2-yl]-10-phenylphenazin-5-yl]phenyl]-5-phenyl-1,3,4-oxadiazole
CID 129156625
2-phenyl-5-[4-[3-phenyl-5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]-1,2,4-triazol-4-yl]phenyl]-1,3,4-oxadiazole
CID 58692859
5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine
CID 118898296
4-[10-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenoxazin-4-yl]-10-[4-[5-(4-phenoxazin-10-ylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]phenoxazine
CID 146530417
4-[4-[4,5-bis[4-[4-(N-phenylanilino)phenyl]phenyl]-1,2,4-triazol-3-yl]phenyl]-N,N-diphenylaniline
CID 102173771
N,N-diphenyl-4-[2-[2-[4-[4-phenyl-5-(4-phenylphenyl)-1,2,4-triazol-3-yl]phenyl]phenyl]phenyl]aniline
CID 59501541
2,7-bis(4-carbazol-9-ylphenyl)-10-phenyl-9H-acridine;7-carbazol-9-yl-N-(7-carbazol-9-yl-9H-fluoren-2-yl)-N-phenyl-9H-fluoren-2-amine;ethane;2-N,7-N,7-N-triphenyl-2-N-[7-(N-phenylanilino)-9H-fluoren-2-yl]-9H-fluorene-2,7-diamine
CID 162131093
4-phenyl-N-[4-(14-phenyl-14-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2,4,6,8(13),9,11,15,17-nonaen-11-yl)phenyl]-N-(4-phenylphenyl)aniline
CID 129062242
4-phenyl-N-[4-[2-[2-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]phenyl]phenyl]phenyl]-N-(4-phenylphenyl)aniline
CID 59228387
9-phenyl-N-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]-N-(3-phenylphenyl)carbazol-3-amine
CID 58903542
N,N-diphenyl-4-[5-[4-(N-phenylanilino)phenyl]-1,3,4-oxadiazol-2-yl]aniline
CID 19808215
4-[2-[2-[4-[5-(4-naphthalen-2-ylphenyl)-4-phenyl-1,2,4-triazol-3-yl]phenyl]phenyl]phenyl]-N,N-diphenylaniline
CID 59501483

Frequently Asked Questions

What is the IUPAC name of 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole?
The IUPAC name of 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole (CID 160776004) is 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole is O=C1c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc2C(=O)c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc21.O=S1(=O)c2ccc(N3c4ccccc4N(c4ccccc4)c4ccccc43)cc2Cc2cc(N3c4ccccc4N(c4ccccc4)c4ccccc43)ccc21.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)n2-c2ccccc2)cc1.c1ccc(-c2nnc(-c3ccc(N4c5ccccc5N(c5ccccc5)c5ccccc54)cc3)o2)cc1.
What is the InChIKey of 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole?
The InChIKey is RZYKPWTYMHCIKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C74H50N2O2.C49H34N4O2S.C38H27N5.C32H22N4O/c77-73-70-48-34-62(60-31-45-68(46-32-60)76(65-39-25-57(26-40-65)53-17-9-3-10-18-53)66-41-27-58(28-42-66)54-19-11-4-12-20-54)50-72(70)74(78)69-47-33-61(49-71(69)73)59-29-43-67(44-30-59)75(63-35-21-55(22-36-63)51-13-5-1-6-14-51)64-37-23-56(24-38-64)52-15-7-2-8-16-52;54-56(55)48-29-27-38(52-44-23-11-7-19-40(44)50(36-15-3-1-4-16-36)41-20-8-12-24-45(41)52)32-34(48)31-35-33-39(28-30-49(35)56)53-46-25-13-9-21-42(46)51(37-17-5-2-6-18-37)43-22-10-14-26-47(43)53;1-4-14-28(15-5-1)37-39-40-38(43(37)31-18-8-3-9-19-31)29-24-26-32(27-25-29)42-35-22-12-10-20-33(35)41(30-16-6-2-7-17-30)34-21-11-13-23-36(34)42;1-3-11-23(12-4-1)31-33-34-32(37-31)24-19-21-26(22-20-24)36-29-17-9-7-15-27(29)35(25-13-5-2-6-14-25)28-16-8-10-18-30(28)36/h1-50H;1-30,32-33H,31H2;1-27H;1-22H.
What are the key properties of 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole?
2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole has a molecular weight of 2774.35 g/mol, XLogP of 50.84, 25 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2,7-bis(10-phenylphenazin-5-yl)-9H-thioxanthene 10,10-dioxide;2,6-bis[4-(4-phenyl-N-(4-phenylphenyl)anilino)phenyl]anthracene-9,10-dione;5-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]-10-phenylphenazine;2-phenyl-5-[4-(10-phenylphenazin-5-yl)phenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 160776004), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).